Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Appointed director
Quarterly results

ACELRX PHARMACEUTICALS INC (ACRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Quarterly results
10/05/2023 8-K Changes in Registrant's Certifying Accountant, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
08/10/2023 8-K Quarterly results
Docs: "AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
07/31/2023 8-K Quarterly results
07/21/2023 8-K Quarterly results
05/10/2023 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update"
03/16/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits...
12/29/2022 8-K Quarterly results
12/05/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update"
10/25/2022 8-K Quarterly results
09/23/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/12/2022 8-K Quarterly results
08/11/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
07/28/2022 8-K Quarterly results
07/15/2022 8-K Quarterly results
06/02/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
03/31/2022 8-K Other Events  Interactive Data
03/10/2022 8-K Quarterly results
03/01/2022 8-K Quarterly results
02/14/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/12/2022 8-K Acquisition/merger/asset purchase announced
Docs: "Contingent Value Rights Agreement, dated as of January 7, 2022, by and among AcelRx Pharmaceuticals, Inc., James Wilkie, solely in his capacity as the representative of the Lowell stockholders and option holders, and Computershare Inc., and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company, collectively as Rights Agent",
"AcelRx Pharmaceuticals Announces the Closing of its Acquisition of Lowell Therapeutics"
12/03/2021 8-K Quarterly results
11/23/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AcelRx Pharmaceuticals Announces the Appointment of Jill Broadfoot to its Board of Directors Hayward, Calif., November 23, 2021 – AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the appointment of Jill Broadfoot to the company’s Board of Directors. Ms. Broadfoot currently serves as the Chief Financial Officer of aTyr Pharma, Inc., a position she has held since July 2018. Prior to joining aTyr, Ms. Broadfoot served as CFO of Emerald Health Pharmaceuticals and Emerald Health Bioceuticals, where she was responsible for establishing operations for the U.S.-based pharmaceutical and bioceutical entities as well as the establishment of operations, co..."
11/15/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Form of Warrant",
"Opinion of Cooley LLP",
"Purchase Agreement between the Company and the Purchasers"
11/15/2021 8-K Quarterly results
Docs: "AcelRx Pharmaceuticals to Acquire Lowell Therapeutics and Reports Third Quarter 2021 Financial Results"
08/16/2021 8-K Quarterly results
07/29/2021 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
Docs: "Letter"
07/14/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "AcelRx Enters into Licensing Agreement for DZUVEO ® in Europe and In-licensing Agreement for Two Products in the U.S."
06/17/2021 8-K Quarterly results
05/17/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy